activins has been researched along with iodine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kosaka, M; Kotajima, A; Miyamoto, Y; Saito, S; Tsuruo, M | 1 |
| Cracchiolo, JR; de Stanchina, E; Fagin, JA; Ho, AL; Im, SY; Knauf, JA; Krishnamoorthy, GP; Leach, SD; Leandro-Garcia, LJ; Lester, R; Lowe, SW; Luckett, KA; Nagarajah, J; Saqcena, M; Sherman, EJ; Zhao, Z | 1 |
2 other study(ies) available for activins and iodine
| Article | Year |
|---|---|
Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells.
Topics: Activins; Animals; Cells, Cultured; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Epidermal Growth Factor; Growth Substances; Inhibins; Iodine; Swine; Thymidine; Thyroid Gland | 1995 |
Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers.
Topics: Activins; Animals; Follistatin; Humans; Iodides; Iodine Radioisotopes; Ligands; MAP Kinase Signaling System; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Receptor, Transforming Growth Factor-beta Type I; Smad Proteins; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2021 |